Blake Jones, MD
Gastroenterology · Rapid City, SDNPI 1659370930
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,721 of the $2,865 with a category attached, or 60.1%. 10 manufacturers reported payments, led by Kowa Research Institute, Inc. at 50.0% of the total. Reporting peaked in 2024 at $1,942 and has fallen 82.5% since, to $341 in 2025.
Across 39 payments — averaging $73.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kowa Research Institute, Inc.$1K
- Boston Scientific$443
- Johnson & Johnson$391
- Takeda Pharmaceuticals U.S.A., Inc.$320
- AbbVie$96
- Olympus America Inc.$79
- plus $104 from 4 others
Across 193 payments — averaging $2161.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Gilead$125K
- Takeda Pharmaceuticals U.S.A., Inc.$91K
- Madrigal Pharmaceuticals$75K
- AbbVie$62K
- Adare Pharmaceuticals, Inc.$57K
- Pfizer$6K
- plus $264 from 1 others
What the payments were for
- Travel & lodging$1,08038%
- Food & beverage$1,72160%
- Education$632%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kowa Research Institute, Inc. | 2 | $1,432 |
| Boston Scientific | 4 | $443 |
| Johnson & Johnson | 7 | $391 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $320 |
| AbbVie | 5 | $96 |
| Olympus America Inc. | 5 | $79 |
| Medtronic | 1 | $42 |
| Mauna Kea Technologies, Inc. | 1 | $31 |
| Endogastric Solutions, Inc | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tremfya$242
- GENERAL BIOPSY$127
- STELARA$117
How this compares
$2,865 in reported general payments places this provider in the 65th percentile of 41 gastroenterology providers in South Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| StelaraUstekinumab | 11 | $276,651 |
| Humira(Cf) PenAdalimumab | 13 | $88,550 |
| XifaxanRifaximin | 13 | $47,429 |
| Mesalamine | 19 | $20,945 |
| Ursodiol | 17 | $6,769 |
| Budesonide DrBudesonide | 33 | $5,612 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 268 | $4,140 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 110 | $1,784 |
| Omeprazole | 138 | $1,412 |
| Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl | 73 | $1,019 |
| Ondansetron Hcl | 267 | $534 |
| Pantoprazole Sodium | 17 | $280 |
| Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg | 11 | $219 |
| Prednisone | 16 | $180 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonStelara | $391 | $276,65111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 41 gastroenterology providers in South Dakota.
Other gastroenterology in Rapid City
- Ali ZakariaRapid City$17K
- Oksana AleksenkoRapid City$6K
- Erik RabornRapid City$4K
- Andrew KeltsRapid City$4K
- Nathan JaquaRapid City$2K
- Gary BochnaRapid City$859
- Valerie StephensRapid City$304
- Michael McGuireRapid City$244
- Kenneth VogeleRapid City$125
- Dale BachwichRapid City$75
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.